BioNTech SE (BNTX) Invested Capital (2018 - 2025)

BioNTech SE has disclosed Invested Capital across 8 years of filings, most recently posting $409.4 million for Q4 2025.

• Invested Capital for Q4 2025 came in at $409.4 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $1.7 billion (up 195.58% YoY), and the FY2025 annual result was $397.4 million, changed N/A from the prior year.
• Invested Capital came in at $409.4 million for Q4 2025 at BioNTech SE, down from $698.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $15.5 billion in Q4 2021 to a low of $6.2 million in Q4 2022.
• The 5-year median for Invested Capital is $373.6 million (2021), against an average of $1.4 billion.
• Across the five-year window, Invested Capital plunged 99.96% in 2022 and jumped 838.43% in 2023, its largest moves.
• BioNTech SE's Invested Capital stood at $15.5 billion in 2021, then tumbled by 99.96% to $6.2 million in 2022, then soared by 5525.29% to $350.1 million in 2023, then retreated by 24.21% to $265.3 million in 2024, then surged by 54.3% to $409.4 million in 2025.
• The last three Invested Capital figures came in at $409.4 million (Q4 2025), $698.4 million (Q3 2025), and $164.1 million (Q2 2025), per Business Quant data.